63 related articles for article (PubMed ID: 36467989)
21. Prognostic Value of Inflammation-Immunity-Nutrition Score and Inflammatory Burden Index for Hepatocellular Carcinoma Patients After Hepatectomy.
Song R; Ni H; Huang J; Yang C; Qin S; Wei H; Luo J; Huang Y; Xiang B
J Inflamm Res; 2022; 15():6463-6479. PubMed ID: 36467989
[TBL] [Abstract][Full Text] [Related]
22. The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients.
Liang Y; Zhang Z; Zhong D; Lai C; Dai Z; Zou H; Feng T; Shang J; Shi Y; Huang X
Front Oncol; 2022; 12():913731. PubMed ID: 36016629
[TBL] [Abstract][Full Text] [Related]
23. A Nomogram Model Based on the Inflammation-Immunity-Nutrition Score (IINS) and Classic Clinical Indicators for Predicting Prognosis in Extranodal Natural Killer/T-Cell Lymphoma.
He Y; Luo Z; Chen H; Ping L; Huang C; Gao Y; Huang H
J Inflamm Res; 2024; 17():2089-2102. PubMed ID: 38595337
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
25. Nutritional status in patients with hepatocellular carcinoma: Potential relevance for clinical outcome.
van Dijk AM; Coppens BJP; van Beers MA; Bruins Slot AS; Verstraete CJR; de Bruijne J; Vleggaar FP; van Erpecum KJ
Eur J Intern Med; 2022 Oct; 104():80-88. PubMed ID: 35902333
[TBL] [Abstract][Full Text] [Related]
26. Tumor-associated neutrophils and neutrophil-targeted cancer therapies.
Que H; Fu Q; Lan T; Tian X; Wei X
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188762. PubMed ID: 35853517
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Roles of Inflammation- and Nutrition-Based Indicators for Female Patients with Cancer.
Yang M; Zhang Q; Ge Y; Tang M; Hu C; Wang Z; Zhang X; Song M; Ruan G; Zhang X; Liu T; Xie H; Zhang H; Zhang K; Li Q; Li X; Liu X; Lin S; Shi H
J Inflamm Res; 2022; 15():3573-3586. PubMed ID: 35747251
[TBL] [Abstract][Full Text] [Related]
28. A Nomogram Model for Predicting Recurrence of Stage I-III Endometrial Cancer Based on Inflammation-Immunity-Nutrition Score (IINS) and Traditional Classical Predictors.
Jiang P; Wang J; Gong C; Yi Q; Zhu M; Hu Z
J Inflamm Res; 2022; 15():3021-3037. PubMed ID: 35645577
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the Value of Multiple Preoperative Objective Nutritional Indices for the Evaluation of Prognosis after Hepatectomy for Hepatocellular Carcinoma.
Qian W; Xiao-Jian J; Jun H; Liang L; Xiao-Yong C
Nutr Cancer; 2022; 74(9):3217-3227. PubMed ID: 35533004
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory burden as a prognostic biomarker for cancer.
Xie H; Ruan G; Ge Y; Zhang Q; Zhang H; Lin S; Song M; Zhang X; Liu X; Li X; Zhang K; Yang M; Tang M; Song CH; Shi H
Clin Nutr; 2022 Jun; 41(6):1236-1243. PubMed ID: 35504166
[TBL] [Abstract][Full Text] [Related]
31. Combining Pre- and Postoperative Lymphocyte-C-Reactive Protein Ratios Can Better Predict Hepatocellular Carcinoma Prognosis After Partial Hepatectomy.
Ni HH; Lu Z; Huang X; Ning SW; Liang XL; Zhang SY; Xiang BD
J Inflamm Res; 2022; 15():2229-2241. PubMed ID: 35411168
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and C-Reactive Protein/Albumin Ratio in Luminal Breast Cancers With HER2-Negativity.
Chen F; Chen D; Jin L; Xu C; Zhao W; Hu W
Front Oncol; 2022; 12():845935. PubMed ID: 35317078
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of inflammation-immunity-nutrition score in patients with hepatocellular carcinoma treated with anti-PD-1 therapy.
Zhang Z; Liang Y; Zhong D; Dai Z; Shang J; Lai C; Zou H; Yao Y; Feng T; Huang X
J Clin Lab Anal; 2022 May; 36(5):e24336. PubMed ID: 35312116
[TBL] [Abstract][Full Text] [Related]
34. Combination of C-Reactive Protein and Neutrophil-to-Lymphocyte Ratio as a Novel Prognostic Index in Patients With Bladder Cancer After Radical Cystectomy.
Wang Y; Wang K; Ni J; Zhang H; Yin L; Zhang Y; Shi H; Zhang T; Zhou N; Mao W; Peng B
Front Oncol; 2021; 11():762470. PubMed ID: 34926263
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
